跳至主要内容
临床试验/JPRN-jRCTs031190200
JPRN-jRCTs031190200已完成未知

Investigation of the effects of medical moisturizers application amount on therapeutic effect for asteatosis

Tsunemi Yuichiro0 个研究点目标入组 60 人开始时间: 2020年2月4日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
60

研究概览

简要总结

In this study, even in the low-dose group, continuous application twice a day improved skin symptom during the study period of 4 weeks. From this result, it has been clarified that if high adherence to application can be maintained, it takes time for the effect to become apparent, but the symptoms can be alleviated and cured. In the recommended dose group, skin symptoms improved early after the start of treatment. Even in actual clinical practice, it was considered that the therapeutic effect would appear f

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • 1) Patients with asteatosis have Overall Dry Skin Score of 3 (without inflammation) on the lower thigh at the start date of treatment
  • 2) Patients 20-years and older at the time of informed consent

排除标准

  • (1) Patients who had following medical history
  • 1) serious allergies (shock, anaphylaxis)
  • 2) hypersensitivity to the products included Heparinoid
  • 3) skin hypersensitivity to any topical product (e.g. contact dermatitis)
  • (2) Patients complicated with following disease
  • 1) any severe disease determined by investigator to be unsuitable for the study, e.g. cardiac, liver, kidney, lung, blood,
  • 2) malignant tumor, except for there is no treatment and no recurrence for the past 5 years, or history of curative treatment for the cervical intraepithelial neoplasia at the time of informed consent
  • 3) skin disease except for asteatosis at the skin evaluation area of this study
  • 4) Hemorrhagic blood diseases e.g. hemophilia, thrombocytopenia, purpura
  • (3) Patients who had a few bleed might induce serious effect
  • (4) Patients who have participated in this study
  • (5) Patients who participate in another clinical trial, clinical study, and post-marketing clinical trial
  • (6) Patients who used the any topical preparation(including over-the-counter drug, quasi-drugs, cosmetics) for the thigh within 14 days prior to treatment starting date
  • (7) Patients who have used antihistamines or allergy medications within the 14 days preceding the start of treatment
  • (8) Patients who have used systemically administered steroids within the three months preceding the start of treatment
  • (9) Patients who is in the situation of pregnancy or breastfeeding or have a possibility of pregnancy
  • (10) Patients who are judged as ineligible for this study by the investigator

研究者

发起方
Tsunemi Yuichiro

相似试验